ST目药
(600671)
| 流通市值：11.04亿 | | | 总市值：11.05亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 30,426,181.81 | 71,310,865.17 | 55,920,693.46 | 97,962,612.42 |
| 应收票据及应收账款 | 64,035,560.53 | 31,473,384.29 | 39,943,389.1 | 36,683,351.8 |
| 应收账款 | 64,035,560.53 | 31,473,384.29 | 39,943,389.1 | 36,683,351.8 |
| 应收款项融资 | - | 1,352,778.33 | 400,695 | 277,402.5 |
| 预付款项 | 6,289,813.4 | 6,427,641.89 | 5,936,438.05 | 1,100,553.86 |
| 其他应收款合计 | 2,091,933.73 | 2,350,435.93 | 2,127,991.2 | 2,004,047.46 |
| 存货 | 46,732,499.13 | 53,217,485.84 | 45,361,388.9 | 42,946,392.19 |
| 其他流动资产 | 729,272.98 | 1,330,517.44 | 688,213.45 | 524,893.04 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 150,305,261.58 | 167,463,108.89 | 150,378,809.16 | 181,499,253.27 |
| 非流动资产: | | | | |
| 固定资产 | 166,998,592.65 | 134,817,067.98 | 137,256,662.33 | 139,780,421.89 |
| 在建工程 | 970,325.48 | 5,527,433.9 | 17,400 | 17,400 |
| 使用权资产 | 26,578,457.39 | 11,423,407.55 | 12,306,170.86 | 11,865,309.09 |
| 无形资产 | 5,126,708.01 | 5,165,405.91 | 5,176,227.7 | 5,214,925.6 |
| 商誉 | 2,198,559.52 | 2,198,559.52 | - | 2,198,559.52 |
| 长期待摊费用 | 10,561,595.14 | 3,141,304.63 | 2,198,559.52 | 2,198,785.25 |
| 递延所得税资产 | 3,611,799.02 | 3,411,936.7 | 1,831,588.36 | 3,513,901.71 |
| 其他非流动资产 | - | - | 3,513,901.71 | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 216,046,037.21 | 165,685,116.19 | 162,300,510.48 | 164,789,303.06 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 366,351,298.79 | 333,148,225.08 | 312,679,319.64 | 346,288,556.33 |
| 流动负债: | | | | |
| 短期借款 | 87,450,000 | 72,565,186.04 | 72,450,000 | 102,639,312.21 |
| 应付票据及应付账款 | 85,793,667.99 | 69,871,271.9 | 65,048,754.51 | 51,219,131.45 |
| 其中：应付票据 | 15,923,890.37 | 19,034,617.06 | 6,548,268.18 | - |
| 应付账款 | 69,869,777.62 | 50,836,654.84 | 58,500,486.33 | 51,219,131.45 |
| 合同负债 | 3,574,371.79 | 2,764,522.46 | 3,807,635.51 | 3,390,440.62 |
| 应付职工薪酬 | 4,007,252.52 | 4,476,112.2 | 6,237,058 | 6,775,032.24 |
| 应交税费 | 8,473,623.4 | 1,420,735.85 | 3,838,509.04 | 4,720,606.85 |
| 其他应付款合计 | 37,237,357.1 | 70,770,621.19 | 42,985,236.89 | 46,273,710.16 |
| 应付股利 | 23,403.36 | 23,403.36 | 23,403.36 | 23,403.36 |
| 一年内到期的非流动负债 | 3,316,726.6 | 4,096,263.58 | 3,954,171.47 | 4,895,572.47 |
| 其他流动负债 | 460,766.45 | 358,634.32 | 489,475.13 | 464,416.75 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 230,313,765.85 | 226,323,347.54 | 198,810,840.55 | 220,378,222.75 |
| 非流动负债: | | | | |
| 租赁负债 | 21,327,754.79 | 6,298,239.95 | 6,387,587.2 | 7,231,567.01 |
| 预计负债 | - | 83,326.32 | 1,147,568.19 | 1,147,568.19 |
| 递延收益 | 55,420,336.6 | 56,452,592.99 | 57,516,995.69 | 58,616,410.52 |
| 递延所得税负债 | 2,779,061.18 | 2,855,851.88 | 2,966,327.27 | 2,966,327.27 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 79,527,152.57 | 65,690,011.14 | 68,018,478.35 | 69,961,872.99 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 309,840,918.42 | 292,013,358.68 | 266,829,318.9 | 290,340,095.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 121,778,885 | 121,778,885 | 121,778,885 | 121,778,885 |
| 资本公积 | 162,787,915.98 | 162,787,915.98 | 162,787,915.98 | 162,787,915.98 |
| 盈余公积 | 24,181,414.37 | 24,181,414.37 | 24,181,414.37 | 24,181,414.37 |
| 未分配利润 | -275,305,704.34 | -290,110,887.23 | -281,332,941.76 | -271,610,158.28 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 33,442,511.01 | 18,637,328.12 | 27,415,273.59 | 37,138,057.07 |
| 少数股东权益 | 23,067,869.36 | 22,497,538.28 | 18,434,727.15 | 18,810,403.52 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 56,510,380.37 | 41,134,866.4 | 45,850,000.74 | 55,948,460.59 |
| 负债和股东权益合计 | 366,351,298.79 | 333,148,225.08 | 312,679,319.64 | 346,288,556.33 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |